Clinical Trials | September 01, 2022
Daiichi Sankyo announces initiation of Phase 3 Trial of mRNA
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
COVID-19 Vaccine (DS-5670) in Unvaccinated Individuals in Japan
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
It is high time that India assumed a leadership role in healthcare.
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
Strand Life Sciences has sequenced a total of 12800 samples from July, 2021 to June, 2022, and identified more than a 100 lineages circulating in Bengaluru
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Company is investing more than €100 million in the expansion of the Halle site
Subscribe To Our Newsletter & Stay Updated
